Sundfeldt M, Carlsson LV, Johansson CB, Thomsen P, Gretzer C. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop. 2006;77(2):177–97. https://doi.org/10.1080/17453670610045902 Epub 2006/06/06. doi: PubMed PMID: 16752278.
Article
PubMed
Google Scholar
Marshall A, Ries MD, Paprosky W, Clinic IWS. How prevalent are implant wear and osteolysis, and how has the scope of osteolysis changed since 2000? J Am Acad Orthop Sur. 2008;16:S1–6. https://doi.org/10.5435/00124635-200800001-00003 PubMed PMID: WOS:000257474600003.
Article
Google Scholar
Baker PN, McMurtry IA, Chuter G, Port A, Anderson J. THA with the ABG I prosthesis at 15 Years: excellent survival with minimal osteolysis. Clin Orthop Relat R. 2010;468(7):1855–61. https://doi.org/10.1007/s11999-009-1066-5 PubMed PMID: WOS:000278521400021.
Article
CAS
Google Scholar
Saleh KJ, Thongtrangan I, Schwarz EM. Osteolysis - medical and surgical approaches. Clin Orthop Relat R. 2004;427:138–47. https://doi.org/10.1097/01.blo.0000142288.66246.4d PubMed PMID: WOS:000224422500024.
Article
Google Scholar
Cale A, Christensen CP, Greenwald AS, McKellop H. Clinical performance of highly cross-linked polyethylenes in total hip arthroplasty. J Bone Joint Surg Am. 2007;89a(12):2779–86. https://doi.org/10.2106/Jbjs.G.00043 PubMed PMID: WOS:000251401900026.
Article
Google Scholar
Ribera A, Morata L, Moranas J, Agullo JL, Martinez JC, Lopez Y, et al. Clinical and microbiological findings in prosthetic joint replacement due to aseptic loosening. J Infection. 2014;69(3):235–43. https://doi.org/10.1016/j.jinf.2014.05.003 PubMed PMID: WOS:000341988500004.
Article
CAS
Google Scholar
Cadosch D, Schlett CL, Gautschi OP, Frei HC, Filgueira L. Metal Ions: Important Co-Players in Aseptic Loosening. Z Orthop Unfallchir. 2010;148(4):393–7. https://doi.org/10.1055/s-0030-1250108 PubMed PMID: WOS:000281465300003.
Article
CAS
Google Scholar
Otto M, Kriegsmann J, Gehrke T, Bertz S. Wear particles: key to aseptic prosthetic loosening? Pathologe. 2006;27(6):447–60. https://doi.org/10.1007/s00292-006-0868-4 PubMed PMID: WOS:000242672500008.
Article
CAS
PubMed
Google Scholar
Horowitz SM, Doty SB, Lane JM, Burstein AH. Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone-resorption. J Bone Joint Surg Am. 1993;75a(6):802–13. https://doi.org/10.2106/00004623-199306000-00002 PubMed PMID: WOS:A1993LK82800002.
Article
Google Scholar
Shimizu S, Okuda N, Kato N, Rittling SR, Okawa A, Shinomiya K, et al. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages. Arthritis Rheum. 2010;62(5):1329–37. https://doi.org/10.1002/art.27400 Epub 2010/02/16. PubMed PMID: 20155835.
Article
CAS
PubMed
Google Scholar
Goodman SB, Gibon E, Yao Z. The basic science of periprosthetic osteolysis. Instr Course Lect. 2013;62:201–6 Epub 2013/02/12. PubMed PMID: 23395025; PubMed Central PMCID: PMCPMC3766766.
PubMed
PubMed Central
Google Scholar
Idris AI, Rojas J, Greig IR, Van't Hof RJ, Ralston SH. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int. 2008;82(3):191–201. https://doi.org/10.1007/s00223-008-9104-y Epub 2008/02/09. PubMed PMID: 18259679.
Article
CAS
PubMed
Google Scholar
Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials. 2004;25(18):4105–15. https://doi.org/10.1016/j.biomaterials.2003.11.024 Epub 2004/03/30. PubMed PMID: 15046901.
Article
CAS
PubMed
Google Scholar
Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, et al. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone. 2004;34(1):112–23. https://doi.org/10.1016/j.bone.2003.08.013 Epub 2004/01/31. PubMed PMID: 14751568.
Article
CAS
PubMed
Google Scholar
Millett PJ, Allen MJ, Bostrom MP. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am. 2002;84(2):236–49. https://doi.org/10.2106/00004623-200202000-00011 Epub 2002/02/28. PubMed PMID: 11861730.
Article
PubMed
Google Scholar
Wise LM, Waldman SD, Kasra M, Cheung R, Binnington A, Kandel RA, et al. Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog. Calcif Tissue Int. 2005;77(6):367–75. Epub 2005/12/20. PubMed PMID: 16362454. https://doi.org/10.1007/s00223-005-0062-3.
Article
CAS
PubMed
Google Scholar
Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res. 2000;18(6):849–55. Epub 2001/02/24. PubMed PMID: 11192243. https://doi.org/10.1002/jor.1100180602.
Article
CAS
PubMed
Google Scholar
Kim SW, Park DJ, Park KS, Kim SY, Cho BY, Lee HK, et al. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis. Endocr J. 2005;52(6):667–74. https://doi.org/10.1507/endocrj.52.667 PubMed PMID: WOS:000234793800003.
Article
CAS
PubMed
Google Scholar
Kaneko J, Okinaga T, Hikiji H, Ariyoshi W, Yoshiga D, Habu M, et al. Zoledronic acid exacerbates inflammation through M1 macrophage polarization. Inflamm Regen. 2018;38:ARTN 16. https://doi.org/10.1186/s41232-018-0074-9 PubMed PMID: WOS:000448308700001.
Article
CAS
Google Scholar
Dhillon S. Zoledronic acid (Reclast((R)), Aclasta((R))): a review in osteoporosis. Drugs. 2016;76(17):1683–97. https://doi.org/10.1007/s40265-016-0662-4 Epub 2016/11/20. PubMed PMID: 27864686.
Article
CAS
PubMed
Google Scholar
Standal T, Johnson RW, McGregor NE, Poulton IJ, Ho PWM, Martin TJ, et al. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation. J Endocrinol. 2014;223(2):181–90. https://doi.org/10.1530/Joe-14-0424 PubMed PMID: WOS:000343659000011.
Article
CAS
PubMed
Google Scholar
Kuriwaka-Kido R, Kido S, Miyatani Y, Ito Y, Kondo T, Omatsu T, et al. Parathyroid Hormone (1–34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. Endocrinology. 2013;154(3):1156–67. https://doi.org/10.1210/en.2013-1915 PubMed PMID: WOS:000315293100017.
Article
CAS
PubMed
Google Scholar
Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1–34) on implant fixation. Clin Orthop Relat R. 2001;(392):427–32. https://doi.org/10.1097/00003086-200111000-00056.PubMed PMID: WOS:000172087100056.
Dohke T, Iba K, Hanaka M, Kanaya K, Okazaki S, Yamashita T. Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression. J Bone Miner Metab. 2018;36(5):499–507. https://doi.org/10.1007/s00774-017-0865-0 PubMed PMID: WOS:000442855100001.
Article
CAS
PubMed
Google Scholar
Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum. 2006;54(10):3221–32. https://doi.org/10.1002/art.22134 PubMed PMID: WOS:000241260800022.
Article
CAS
PubMed
Google Scholar
Beraudi A, Stea S, Cremonini S, Visentin M, Toni A. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty. Artif Organs. 2009;33(7):538–43. https://doi.org/10.1111/j.1525-1594.2009.00736.x PubMed PMID: WOS:000267170200006.
Article
CAS
PubMed
Google Scholar
Yang SY, Yu HY, Gong WM, Wu B, Mayton L, Costello R, et al. Murine model of prosthesis failure for the long-term study of aseptic loosening. J Orthop Res. 2007;25(5):603–11. https://doi.org/10.1002/jor.20342 PubMed PMID: WOS:000245728000005.
Article
PubMed
Google Scholar
Qian Y, Zeng BF, Zhang XL, Jiang Y. Substance P stimulates production of interleukin 1beta and tumor necrosis factor alpha in fibroblasts from hip periprosthetic membrane. J Arthroplast. 2008;23(4):581–5. https://doi.org/10.1016/j.arth.2007.06.010 Epub 2008/06/03. PubMed PMID: 18514878.
Article
Google Scholar
Tashjian RZ, Lin C, Aswad B, Terek RM. 11beta-hydroxysteroid dehydrogenase type 1 expression in periprosthetic osteolysis. Orthopedics. 2008;31(6):545 Epub 2009/03/19. PubMed PMID: 19292355.
PubMed
Google Scholar
Brulefert K, Cordova LA, Brulin B, Faucon A, Hulin P, Nedellec S, et al. Pro-osteoclastic in vitro effect of polyethylene-like nanoparticles: involvement in the pathogenesis of implant aseptic loosening. J Biomed Mater Res A. 2016;104(11):2649–57. https://doi.org/10.1002/jbm.a.35803 Epub 2016/06/03. PubMed PMID: 27254768.
Article
CAS
PubMed
Google Scholar
Talmo CT, Shanbhag AS, Rubash HE. Nonsurgical management of osteolysis: challenges and opportunities. Clin Orthop Relat Res. 2006;453:254–64. https://doi.org/10.1097/01.blo.0000246531.59876.a8 Epub 2006/10/04. PubMed PMID: 17016218.
Article
PubMed
Google Scholar
Geng DC, Xu YZ, Yang HL, Zhu XS, Zhu GM, Wang XB. Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630. J Biomed Mater Res Part A. 2010;95a(1):321–6. https://doi.org/10.1002/jbm.a.32836 PubMed PMID: WOS:000281448700033.
Article
CAS
Google Scholar
Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000;15(1):2–12. https://doi.org/10.1359/jbmr.2000.15.1.2 PubMed PMID: WOS:000084420800003.
Article
CAS
PubMed
Google Scholar
Lochner K, Fritsche A, Jonitz A, Hansmann D, Mueller P, Mueller-Hilke B, et al. The potential role of human osteoblasts for periprosthetic osteolysis following exposure to wear particles. Int J Mol Med. 2011;28(6):1055–63. https://doi.org/10.3892/ijmm.2011.778 PubMed PMID: WOS:000296314600020.
Article
CAS
PubMed
Google Scholar
Abbas S, Clohisy JC, Abu-Amer Y. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res. 2003;21(6):1041–8. https://doi.org/10.1016/S0736-0266(03)00081-0 PubMed PMID: WOS:000186144200012.
Article
CAS
PubMed
Google Scholar
Jiang YP, Jia TH, Wooley PH, Yang SY. Current research in the pathogenesis of aseptic implant loosening associated with particulate wear debris. Acta Orthop Belg. 2013;79(1):1–9 PubMed PMID: WOS:000326420500001.
PubMed
Google Scholar
Wang ZH, Liu NC, Liu K, Zhou G, Gan JJ, Wang ZZ, et al. Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis. Autophagy. 2015;11(12):2358–69. https://doi.org/10.1080/15548627.2015.1106779 PubMed PMID: WOS:000367806300019.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang YY, Lin Y, Xiao LL, Feng EY, Wang WL, Lin LQ. The effects of icariine concentration on osteoclasts bone resorption induced by titanium particles in vitro. Regen Biomater. 2015;2(3):197–202. https://doi.org/10.1093/rb/rbv002 PubMed PMID: WOS:000218550700005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zenios M, Nokes L, Galasko CSB. Effect of a bisphosphonate, disodiurn pamidronate, on the quasi-static flexural properties of palacos R acrylic bone cement. J Biomed Mater Res B. 2004;71b(2):322–6. https://doi.org/10.1002/jbm.b.30101 PubMed PMID: WOS:000224846700013.
Article
CAS
Google Scholar
Goodship AE, Walker PC, McNally D, Chambers T, Green JR. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol. 1994;5(Suppl 7):S53–5 Epub 1994/01/01. PubMed PMID: 7873463.
PubMed
Google Scholar
Koivukangas A, Taukkanen J, Kippo K, Jamsa T, Hannuniemi R, Pasanen I, et al. Long-term administration of clodronate does not prevent fracture healing in rats. Clin Orthop Relat R. 2003;(408):268–78. https://doi.org/10.1097/01.blo.0000053054.62337.e1 PubMed PMID: WOS:000181436700037.
Li CY, Mori S, Li JL, Kaji Y, Akiyama T, Kawanishi J, et al. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res. 2001;16(3):429–36. https://doi.org/10.1359/jbmr.2001.16.3.429 PubMed PMID: WOS:000167157700001.
Article
CAS
PubMed
Google Scholar
Yalcin N, Ozturk A, Ozkan Y, Celimli N, Ozocak E, Erdogan A, et al. The effects of zoledronic acid and hyperbaric oxygen on posterior lumbar fusion in a rabbit model. J Bone Joint Surg Br. 2011;93b(6):793–800. https://doi.org/10.1302/0301-620x.93b6.24257 PubMed PMID: WOS:000290714900015.
Article
Google Scholar
Suratwala SJ, Cho SK, van Raalte JJ, Park SH, Seo SW, Chang SS, et al. Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite. J Bone Joint Surg Am. 2008;90a(10):2189–96. https://doi.org/10.2106/Jbjs.G.00409 PubMed PMID: WOS:000259873300017.
Article
Google Scholar
Labrinidis A, Hay S, Liapis V, Ponomarev V, Findlay DM, Evdokiou A. EZoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model. Clin Cancer Res. 2009;15(10):3451–61. https://doi.org/10.1158/1078-0432.Ccr-08-1616 PubMed PMID: WOS:000266282600024.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wedemeyer C, von Knoch F, Pingsmann A, Hilken G, Sprecher C, Saxler G, et al. Stimulation of bone formation by zoledronic acid in particle-induced osteolysis. Biomaterials. 2005;26(17):3719–25. https://doi.org/10.1016/j.biomaterials.2004.09.026 PubMed PMID: WOS:000226968200038.
Article
CAS
PubMed
Google Scholar
Tang ZL, Bai S, Zhu PN, Li YD, Wang DX, Cai Y. An examination of differences in the new bone formation promoted by different doses of recombinant human parathyroid hormone during mandibular distraction osteogenesis. Plast Reconstr Surg. 2016;137(2):347e–54e. https://doi.org/10.1097/01.prs.0000475780.68585.cc PubMed PMID: WOS:000369444500001.
Article
CAS
PubMed
Google Scholar
Noordin S, Glowacki J. Parathyroid hormone and its receptor gene polymorphisms: implications in osteoporosis and in fracture healing. Rheumatol Int. 2016;36(1):1–6. https://doi.org/10.1007/s00296-015-3319-9 PubMed PMID: WOS:000367808500001.
Article
CAS
PubMed
Google Scholar
Winarno AS, Kyvernitakis I, Hadji P. Successful treatment of 1–34 parathyroid hormone (pth) after failure of bisphosphonate therapy in a complex case of pregnancy associated osteoporosis and multiple fractures. Z Geburtsh Neonatol. 2014;218(4):171–3. https://doi.org/10.1055/s-0034-1382069 PubMed PMID: WOS:000340831000010.
Article
CAS
Google Scholar
Hegde V, Jo JE, Andreopoulou P, Lane JM. Effect of osteoporosis medications on fracture healing. Osteoporosis Int. 2016;27(3):861–71. https://doi.org/10.1007/s00198-015-3331-7 PubMed PMID: WOS:000371311400003.
Article
CAS
Google Scholar
Brunnemann CE, Reisinger EC, Ganzer D, Schober HC. Parathyroid hormone injection to counteract delayed bone fractures. Deut Med Wochenschr. 2010;135(31–32):1538–41. https://doi.org/10.1055/s-0030-1262443 PubMed PMID: WOS:000280369300003.
Article
CAS
Google Scholar
Casanova M, Herelle J, Thomas M, Softley R, Schindeler A, Little D, et al. Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition. Bone. 2016;92:70–8. https://doi.org/10.1016/j.bone.2016.08.012 PubMed PMID: WOS:000385693400008.
Article
CAS
PubMed
Google Scholar
Daugaard H, Elmengaard B, Andreassen TT, Lamberg A, Bechtold JE, Soballe K. Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone A canine study. Acta Orthopaedica. 2012;83(4):411–9. https://doi.org/10.3109/17453674.2012.702388 PubMed PMID: WOS:000307848600016.
Article
PubMed
PubMed Central
Google Scholar
Bloebaum RD, Willie BM, Mitchell BS, Hofmann AA. Relationship between bone ingrowth, mineral apposition rate, and osteoblast activity. J Biomed Mater Res Part A. 2007;81a(2):505–14. https://doi.org/10.1002/jbm.a.31087 PubMed PMID: WOS:000245688500028.
Article
CAS
Google Scholar
Yu XH, Wang LP, Jiang X, Rowe D, Wei M. Biomimetic CaP coating incorporated with parathyroid hormone improves the osseointegration of titanium implant. J Mater Sci-Mater M. 2012;23(9):2177–86. https://doi.org/10.1007/s10856-012-4682-7 PubMed PMID: WOS:000308242000014.
Article
CAS
Google Scholar
Zati A, Sarti D, Malaguti MC, Pratelli L. Teriparatide in the treatment of a loose hip prosthesis. J Rheumatol. 2011;38(4):778–80. https://doi.org/10.3899/jrheum.100980 PubMed PMID: WOS:000289333800035.
Article
PubMed
Google Scholar
Dayer R, Brennan TC, Rizzoli R, Ammann P. PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet. Osteoporosis Int. 2010;21(6):957–67. https://doi.org/10.1007/s00198-009-1031-x PubMed PMID: WOS:000277204100008.
Article
CAS
Google Scholar
Skripitz R, Johansson HR, Ulrich SD, Werner A, Aspenberg P. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats. J Orthop Sci. 2009;14(2):138–43. https://doi.org/10.1007/s00776-008-1311-x PubMed PMID: WOS:000264838400003.
Article
CAS
PubMed
Google Scholar
Daugaard H. The influence of Parathyroid hormone treatment on implant fixation. Dan Med Bull. 2011;58(9):B4317. PubMed PMID: WOS:000297626800008.